Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light
This article is from
The Cancer Letter
archive.
Vol. 40 No. 45 | December 5, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Cell Therapeutics To Appeal FDA Decision on Pixantrone.
September 17, 2010
TCL Archive
DCBDC Board Ok’s New Initiative For Training
November 16, 1990
TCL Archive
Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.
March 17, 2000
TCL Archive
Costs of Rosenberg Regimen Could Hinder cooperative Group Trials
January 3, 1986
TCL Archive
More Women Over 50 Report Having Had Mammograms.
July 28, 2000
TCL Archive
NCI-Approved Clinical Trials
November 24, 2006